Joren Callaert
Overview
Explore the profile of Joren Callaert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deloose K, Gielis J, Maene L, Lansink W, Lerut P, Verbist J, et al.
J Cardiovasc Surg (Torino)
. 2025 Jan;
66(1):37-45.
PMID: 39878064
Background: Due to the heterogeneity of literature findings, stent type selection for the endovascular treatment of complex aorto-iliac occlusive disease remains challenging. The BELSTREAM study, a physician-initiated, prospective, multicenter, single-arm...
2.
Bosiers M, Deloose K, Torsello G, Scheinert D, Verbist J, VAN DEN Eynde W, et al.
J Cardiovasc Surg (Torino)
. 2024 Dec;
65(6):509-514.
PMID: 39655907
Background: To investigate the long-term efficacy of the paclitaxel-eluting Legflow balloon catheter in the treatment of "real-world" long and complex femoropopliteal lesions. Methods: The REFLOW study was a prospective, multi-national,...
3.
Deloose K, Lansink W, Brodmann M, Werner M, Keirse K, Goueffic Y, et al.
JACC Cardiovasc Interv
. 2023 Dec;
16(23):2900-2914.
PMID: 38092496
Background: There is a scarcity of published head-to-head comparisons between different paclitaxel-coated angioplasty balloons. More prospective safety data to support the health care economic reimbursement processes are needed. Objectives: The...
4.
Bosiers M, De Donato G, Torsello G, Silveira P, Scheinert D, Veroux P, et al.
Cardiovasc Intervent Radiol
. 2023 Sep;
46(10):1348-1358.
PMID: 37670198
Purpose: To report the 60-month safety and effectiveness results of a multicenter, prospective, randomized controlled trial comparing the ZILVER PTX paclitaxel-eluting stent to prosthetic above-the-knee bypass for the treatment of...
5.
Mousati Z, Van Den Broek M, Callaert J, Gielis J, Govaers K
Trauma Case Rep
. 2023 Jul;
46:100873.
PMID: 37396117
Background: Trochanteric fractures are very common hip injuries often fixed with intramedullary nailing as the recommended treatment. Medial lag screw migration of the intramedullary nail system is an uncommon complication....
6.
Bosiers M, De Donato G, Torsello G, Silveira P, Deloose K, Scheinert D, et al.
J Cardiovasc Surg (Torino)
. 2023 May;
64(4):413-421.
PMID: 37162238
Background: To report the 3-year safety and effectiveness results of a multicenter, prospective, randomized controlled trial comparing the ZILVER PTX paclitaxel-eluting stent to surgical bypass and to conduct a health...
7.
Dullens L, Decloedt H, Gielis J, Callaert J, Deloose K
Surg Technol Int
. 2023 Jan;
42:193-195.
PMID: 36602184
A thyroglossal duct cyst (TGDC) is the result of incomplete degeneration of the thyroglossal duct during gestation. It is the most common type of congenital cyst of the neck, and...
8.
Bosiers M, Deloose K, Callaert J, Verbist J, Hendriks J, Lauwers P, et al.
J Cardiovasc Surg (Torino)
. 2020 Nov;
61(5):617-625.
PMID: 33231029
Background: This clinical trial aims to evaluate the outcome (up to 24-months) of the treatment of in-stent restenotic or reoccluded lesions in the femoropopliteal arteries, by comparing the treatment of...
9.
Bosiers M, Deloose K, Torsello G, Scheinert D, Verbist J, VAN DEN Eynde W, et al.
J Cardiovasc Surg (Torino)
. 2020 Apr;
61(4):471-477.
PMID: 32241092
Background: The aim of this study is to investigate the efficacy of the paclitaxel-eluting Legflow balloon catheter in the treatment of "real-world" long and complex femoropopliteal lesions. Methods: The REFLOW...
10.
Bosiers M, Setacci C, De Donato G, Torsello G, Silveira P, Deloose K, et al.
J Endovasc Ther
. 2020 Jan;
27(2):287-295.
PMID: 31997715
To report the 12-month results of a multicenter, prospective, randomized controlled trial to determine if the ZILVER PTX paclitaxel-eluting stent was noninferior in terms of safety and efficacy compared with...